+Vote!
Red Orbit (Free subscription) | 12 hours ago
The dramatically new approach to protein misfolding could lead to new therapies for a number of diseasesIn an encouraging new development, a team led by Scripps Research Institute scientists has restored partial function to lung cells collected from patients with cystic fibrosis. While there is still much work to be done before the therapy can be tested in humans, the discovery opens the door to a...
+Vote!
JeyamArticle (Free subscription) | yesterday
Liposuction is more popular than ever and many inquiring minds want to know what can be expected once they get home from the surgery. While there used to be horror stories of people being in agonizing pain after the surgery, now surgeons show patients that are talking on their cell phones during the surgery. While techniques have improved, care of body with liposuction surgery afterwards has remained...
4Vote!
The Boobdex (Free subscription) | yesterday
CBS Video://Kanzius Machine http://kanziuscancerresearch.com/
4Vote!
PR News Wire (Free subscription) | yesterday
NEW ORLEANS, Dec. 5 /PRNewswire-USNewswire/ -- There have been significant scientific advances in the field of blood cancers, and leading experts continue to gain a better understanding of how certain diseases progress in order to discover new treatment options and provide patients with the best care. Research presented today at the 51st Annual Meeting of the American Society of Hematology explores...
+Vote!
SBWire Press Releases (Free subscription) | yesterday
Trent Consultants News: Adults who use pet therapy while recovering from total joint-replacement surgery require 50 percent less pain medication than those who do not.
5Vote!
Red Orbit (Free subscription) | yesterday
--In Youngest Babies, This Type of Blood Cancer Is Most Challenging--PHILADELPHIA and NEW ORLEANS, Dec. 5 /PRNewswire-USNewswire/ -- Pediatric oncologists have identified specific genes, dubbed partner genes, that fuse with another gene to drive an often-fatal form of leukemia in infants. By more accurately defining specific partner genes, researchers expect to better predict which infants may benefit...
4Vote!
Business Wire (Free subscription) | 12/04/2009
WESTMINSTER, Colo.--(BUSINESS WIRE)--Allos Therapeutics, Inc. (Nasdaq: ALTH) today announced the execution of a collaborative agreement with Idis, a UK-based global company, to manage the named patient program for FOLOTYN™ (pralatrexate injection) outside of the United States. The U.S. Food and Drug Administration (FDA) has granted accelerated approval for FOLOTYN for the treatment of patients...
5Vote!
Business Wire (Free subscription) | 12/03/2009
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Gloucester Pharmaceuticals announced today that ISTODAX® (romidepsin) has been included in the updated National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology™ as a suggested systemic treatment option for patients with mycosis fungoides and Sézary syndrome—two of the most common types of cutaneous T-cell lymphoma...
4Vote!
Business Wire (Free subscription) | 12/03/2009
WESTMINSTER, Colo.--(BUSINESS WIRE)--Allos Therapeutics, Inc. (Nasdaq: ALTH) today announced the launch of an international registry designed to address the urgent need to better understand treatment patterns and outcomes for patients with peripheral T-cell lymphoma (PTCL). The registry, known as COMPLETE (Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment), is a global observational...
3Vote!
Radon Mitigation Pittsburgh (Free subscription) | 12/03/2009
December 3, 2009 (FinancialWire) Hana Biosciences (OTCBB: HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, announced that top-line data from its pivotal Phase 2 rALLy clinical trial for Marqibo(R) (vincristine sulfate liposomes injection) for the treatment of adult acute lymphoblastic leukemia in second relapse will be presented at the at the 51st American...
3Vote!
PLoS ONE (Free subscription) | 12/03/2009
Despite highly active antiretroviral therapy (HAART), AIDS related lymphoma (ARL) occurs at a significantly higher rate in patients infected with the Human Immunodeficiency Virus (HIV) than in the general population. HIV-infected macrophages are a known viral reservoir and have been shown to have lymphomagenic potential in SCID mice; therefore, there is an interest in determining if a viral component...
6Vote!
aarkstore | 12/03/2009
Summary The leading business intelligence provider, has released its latest research “The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis.” The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global oncology therapeutics market. The report analyzes the markets for oncology therapeutics
Explore : Breast Cancer,
Business,
Business Intelligence,
Cancers,
Drug Manufacturers,
Health Industries,
Lung Cancer,
Men’s health,
Novartis AG,
Prostate Cancer,
Telecommunication,
Women’s health
3Vote!
Medical News Today (Free subscription) | 12/02/2009
Memgen announced today that results from its ongoing, Leukemia & Lymphoma Society co-sponsored clinical trial in chronic lymphocytic leukemia (CLL) have been selected for an oral presentation at the 51st Annual Meeting of the American Society of Hematology (ASH) in New Orleans, Louisiana. The trial is designed to investigate the safety and efficacy of ISF35 in combination with chemotherapy in patients...
4Vote!
PR News Wire (Free subscription) | 12/02/2009
WHITE PLAINS, N.Y., Dec. 2 /PRNewswire-USNewswire/ -- Researchers from around the world will present their findings in blood cancer research at the annual American Society of Hematology (ASH) conference in New Orleans December 4-8, 2009.
16Vote!
CNN (Free subscription) | 12/02/2009
Following the death of a former Miss Argentina after complications arising from plastic surgery, questions are being raised about the risks of cosmetic surgery.
6Vote!
aarkstore | 12/03/2009
Summary The leading business intelligence provider, has released its latest research “The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis.” The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global oncology therapeutics market. The report analyzes the markets for oncology therapeutics in...
Explore : Breast Cancer,
Business,
Business Intelligence,
Cancers,
Drug Manufacturers,
Health Industries,
Lung Cancer,
Men’s health,
Novartis AG,
Prostate Cancer,
Telecommunication,
Women’s health
5Vote!
carole37i | 11/26/2009
Alcoholism Treatment and Drug Rehab Centers Treatment Centers and alcoholism treatment programs and drug alcohol detox. alcohol rehab,drug rehab,drug abuse,alcoholism treatment,inpatient rehabilitation,halfway house,center,programs,facilites http://www.thewatershed.com
3Vote!
danwolfe1f | 11/22/2009
Tennis Elbow Treatments do not always require a doctor. Learn how to cure tennis elbow without seeing the doctor. Tennis Elbow Treatment, cures for tennis elbow http://curesfortenniselbow.com/tennis-elbow-treatment/
Videos